Benzothiopyranoindole-Based Antiproliferative Agents: Synthesis, Cytotoxicity, Nucleic Acids Interaction, and Topoisomerases Inhibition Properties

被引:30
作者
Dalla Via, Lisa [1 ]
Magno, Sebastiano Marciani [1 ]
Gia, Ornella [1 ]
Marini, Anna Maria [2 ]
Da Settimo, Federico [2 ]
Salerno, Silvia [2 ]
La Motta, Concettina [2 ]
Simorini, Francesca [2 ]
Taliani, Sabrina [2 ]
Lavecchia, Antonio [3 ]
Di Giovanni, Carmen [3 ]
Brancato, Giuseppe [3 ]
Barone, Vincenzo [4 ,5 ]
Novellino, Ettore [3 ]
机构
[1] Univ Padua, Dipartimento Sci Farmaceut, I-35131 Padua, Italy
[2] Univ Pisa, Dipartimento Sci Farmaceut, I-56126 Pisa, Italy
[3] Univ Naples Federico II, Dipartimento Chim Farmaceut & Toosicol, I-80131 Naples, Italy
[4] Scuola Normale Super Pisa, I-56100 Pisa, Italy
[5] IPCF CNR, Area Ric, I-56124 Pisa, Italy
关键词
DNA TOPOISOMERASES; I INHIBITORS; FORCE-FIELD; BINDING; CLEAVAGE; DERIVATIVES; MECHANISMS; RESISTANCE; ENERGIES; PROTEINS;
D O I
10.1021/jm900627v
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Novel benzo[3',2':5,6]thiopyrano[3,2-b]indol-10(11H)-ones la-v were synthesized and evaluated for their antiproliferative activity in an in vitro assay of human tumor cell lines (HL-60 and HeLa). Compounds le-v, substituted at the 11-position with a basic side chain, showed a significant ability to inhibit cell growth with IC50 values in the low micromolar range. Linear dichroism measurements showed that all 11-dialkylaminoalkyl substituted derivatives 1e-v behave as DNA-intercalating agents. Fluorimetric titrations demonstrated their specificity in binding to A-T rich regions, and molecular modeling studies were performed on the most active derivatives (1e, 1i, 1p) to characterize in detail the complexation mechanism of these benzothiopyranoindoles to DNA. A relaxation assay evidenced a dose-dependent inhibition of topoisomerase II activity that appeared in accordance with the antiproliferative capacity. Finally, for the most cytotoxic derivative, 1e, a topoisomerase II poisoning effect was also demonstrated, along with a weak inhibition of topoisomerase I-mediated relaxation.
引用
收藏
页码:5429 / 5441
页数:13
相关论文
共 75 条
[51]  
Osheroff N, 1994, Adv Pharmacol, V29B, P105
[52]   Global cancer statistics in the year 2000 [J].
Parkin, DM .
LANCET ONCOLOGY, 2001, 2 (09) :533-543
[53]   Implementation and validation of DFT-D for molecular vibrations and dynamics: The benzene dimer as a case study [J].
Pavone, Michele ;
Rega, Nadia ;
Barone, Vincenzo .
CHEMICAL PHYSICS LETTERS, 2008, 452 (4-6) :333-339
[54]  
Phillips R.R., 1959, ORG REACTIONS, V10, P143, DOI [10.1002/0471264180.or010.02, DOI 10.1002/0471264180.OR010.02/ABSTRACT]
[55]  
Pommier Y, 1994, Adv Pharmacol, V29B, P73
[56]   Topoisomerase I inhibitors: camptothecins and beyond [J].
Pommier, Yves .
NATURE REVIEWS CANCER, 2006, 6 (10) :789-802
[57]  
Pujol Maria Dolors, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P215, DOI 10.2174/1568011053765930
[58]   Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA [J].
Redinbo, MR ;
Stewart, L ;
Kuhn, P ;
Champoux, JJ ;
Hol, WGJ .
SCIENCE, 1998, 279 (5356) :1504-1513
[59]   Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties of novel indeno[2,1-c]quinolin-7-one and indeno[1,2-c]isoquinolin-5,11-dione derivatives [J].
Ryckebusch, Adina ;
Garcin, Deborah ;
Lansiaux, Amelie ;
Goossens, Jean-Francois ;
Baldeyrou, Brigitte ;
Houssin, Raymond ;
Bailly, Christian ;
Henichart, Jean-Pierre .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (12) :3617-3629
[60]   Recent advances in understanding structure-function relationships in the type II topoisomerase mechanism [J].
Schoeffler, AJ ;
Berger, JM .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2005, 33 :1465-1470